Abstract
It is generally accepted that treated sewage effluent discharges are the principal source of pharmaceutically active compounds and their metabolites from humans into the aquatic environment (Daughton and Ternes 2000, Heberer 2002). As has been discussed in other chapters of this book in order for the sustainable use of pharmaceuticals to become a reality there is a need to understand the complete life cycle of a pharmaceutical compound including the various pathways by which it can enter the aquatic environment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Al-Ahmad A, Daschner FD, Kümmerer K (1999) Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin G, and sulfametohoxazole and inhibition of wastewater bacteria. Arch Environ Con Tox 37, 158–163
Alder AC, McArdell CS, Golet EM, Kohler H-P, Molnar E (2004) Environmental exposure of antibiotics in wastewaters, sewage sludges and surface waters. In: Pharmaceuticals in the Environment. Sources, Fate, Effects and Risks. Springer, Berlin
Boegård C, Coombe V, Holm G, Taylor D (2008). The concentrations and potential environmental impact of pharmaceuticals in the effluent from a major Astrazeneca manufacturing facility. KNAPPE- Pharmaceutical Products in the Environment: Trends toward lowering occurrence and impact. Nimes, France
Bound JP, Kitsou K, Voulvoulis N (2006) Household disposal of pharmaceuticals and perception of risk to the environment. Environ Toxicol Pharmacol 21, 301–307
Bound JP, Voulvoulis N (2005) Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom. Environ Health Perspect 113, 1705–1711
Daughton CG, Ternes TA (2000) Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ Health Perspect 107, 906–946
Duong HA, Pham NH, Nguyen HT, Hoang TT, Pham HV, Pham VC, Berg M, Giger W, Alder AC (2008) Occurrence, after and antibiotic resistance of fluoroquinolone antibacterials in hospital wastewaters in Hanoi, Vietnam. Chemosphere 72, 968–973
Feldmann DF, Zuehlke S, Heberer T (2008) Occurrence, fate and assessment of polar metamizole (dipyrone) residues in hospital and municipal wastewater. Chemosphere 71, 1754–1764
Gomez MJ, Petrovic M, Fernandez-Alba A, Barcelo D (2006) Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography-tandem mass spectrometry analysis in hospital wastewaters. J Chrom A 1114, 224–233
Hartmann A, Alder AC, Koller T, Widmer RM (1998) Identification of fluoroquinolone antibiotics as the main source of umuC genotoxicity in native hospital wastewater. Environ Toxicol Chem 17, 377–382
Hartmann A, Golet EM, Gartiser S, Alder AC, Koller T, Widmer RM (1999) Primary DNA damage but not mutagenicity correlates with ciprofloxacin concentrations in German hospital wastewaters. Arch Environ Cont Toxicol 36, 115–119
Heberer T (2002) Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of recent research data. Toxicol Lett 131, 5–17
Heberer T, Feldmann D (2005) Contribution of effluents from hospitals and private households to the total loads of diclofenac and carbamazepine in municipal sewage effluents-modelling versus measurements. J Hazard Mater 122, 211–218. Erratum in: J Hazard Mater 127, 249
Jarnheimer P-Å, Ottoson J, Lindberg R, Stenstrom T-A, Johansson M, Tysklind M, Winner M-M, Olsen B (2004) Fluoroquinolone antibiotics in a hospital sewage line; occurrence, distribution and impact on bacterial resistance. Scand J Infect Dis 36, 752–755
Kümmerer K (2001) Drugs in the environment: Emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources – A review. Chemosphere 45, 957–969
Kümmerer K (2004a). Pharmaceuticals in the environment – Scope of the book and introduction. In: Pharmaceuticals in the Enviornment. Sources, Fate, Effects and Risks. Springer, Berlin
Kümmerer K (2004b) Resistance in the environment. J Antimicrob Chemo 54, 311–320
Kümmerer K, Henninger A (2003) Promoting resistance by the emission of antibiotics from hospitals and households into effluent. Clin Microbiol Infect 9, 1203–1214
Langford KH, Thomas KV (2009) Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works. Environ Int 35, 766–770
Larsson DGJ, de Pedro C, Paxeus N (2007) Effluent from drug manufactures contains extremely high levels of pharmaceuticals. J Haz Mat 48, 751–755
Lenz K, Koellensperger G, Hann S, Weissenbacher N, Mahnik SN, Fuerhacker M (2007) Fate of cancerostatic platinum compounds in biological wastewater treatment of hospital effluents. Chemosphere 69, 1765–1774
Li D, Yang M, Hu J, Ren L, Yu Z, Li K (2008) Determiantion and fate of oxytetracycline and related compounds in oxytetracycline production wastewater and the receiving river. Environ Toxicol Chem 27, 80–86
Lin AY-C, Tsai Y-T (2009) Occurrence of pharmaceuticals in Taiwan’s surface waters: Impact of waste streams from hospitals and pharmaceutical production facilities. Sci Tot Environ 407, 3793–3802
Lindberg R, Jarnheimer P-Å, Olsen B, Johansson M, Tysklind M (2004) Determination of antibiotic substances in hospital sewage water using solid phase extraction and liquid chromatography/mass spectrometry and group analogue internal standards. Chemosphere 57, 1479–1488
Mahnik SN, Lenz K, Weissenbacher N, Mader RM, Fuerhacker M (2007) Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system. Chemosphere 66, 30–37
Muthanna TM, Plosz BG (2008). The impact of hospital sewage discharge on the assessment of environmental risk posed by priority pharmaceuticals: Hydrodynamic modelling and measurements. 11th International Conference on Urban Drainage, Edinburgh, Scotland
Ohlsen K, Ternes T, Werner G, Wallner U, Loffler D, Ziebuhr W, Witte W, Hacker J (2003) Impact of antibiotics on conjugational resistance gene transfer in Saphylococcus aureus in sewage. Environ Microbiol 5, 711–716
Reinthaler FF, Posch J, Feierl G, Wüst G, Haas D, Ruckenbauer G, Mascher F, Marth E (2003) Antibiotic resistance of E. coli in sewage and sludge. Water Res 37, 1685–1690
Schuster A, Hädrich C, Kümmerer K (2008) Flows of Active Pharmaceutical Ingredients Originating from Health Care Practices on a Local, Regional, and Nationwide Level in Germany—Is Hospital Effluent Treatment an Effective Approach for Risk Reduction? Wat, Air Soil Pollut 8, 457–471
Thomas KV, Langford (2007) Occurrence of pharmaceuticals in the aqueous environment. In Analysis, fate and removal of pharmaceuticals in the water cycle. Elsevier, Amsterdam
Thomas KV, Dye C, Schlabach M, Langford KH (2007) Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works. J Environ Mon 9, 1410
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Thomas, K.V., Langford, K.H. (2010). Point Sources of Human Pharmaceuticals into the Aquatic Environment. In: Kümmerer, K., Hempel, M. (eds) Green and Sustainable Pharmacy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-05199-9_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-05199-9_14
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-05198-2
Online ISBN: 978-3-642-05199-9
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)